Literature DB >> 34658316

Birthweight and subsequent risk for thyroid and autoimmune conditions in postmenopausal women.

Brian Monahan1, Leslie V Farland2, Aladdin H Shadyab3, Susan E Hankinson1, JoAnn E Manson4,5, Cassandra N Spracklen1.   

Abstract

The objective of this study was to determine the association between birthweight and risk of thyroid and autoimmune conditions in a large sample of postmenopausal women. Baseline data from the Women's Health Initiative (n = 80,806) were used to examine the associations between birthweight category (<6 lbs., 6-7 lbs. 15 oz, 8-9 lbs. 15 oz, and ≥10 lbs.) and prevalent thyroid (underactive and overactive thyroid and goiter) and autoimmune (lupus, rheumatoid arthritis (RA), multiple sclerosis, ulcerative colitis/Crohn's disease) conditions. Follow-up questionnaire data were used to examine the associations between birthweight and incident underactive and overactive thyroid, lupus, and RA. Logistic and Cox proportional hazards regression models were used to estimate crude and adjusted odds (OR) and hazards ratios (HR), respectively. Overall, women born weighing ≥10 lbs. had an increased risk for underactive thyroid [OR 1.14 (95% CI 1.02, 1.28)] and incident lupus [HR 1.51 (95% CI 1.12, 2.03)] and a decreased risk for overactive thyroid [OR 0.67 (95% CI 0.50, 0.92)] compared to women born weighing 6-7.99 lbs., after adjustment for adult BMI, demographic variables, and lifestyle factors. Further, women born weighing <6 lbs. were at increased risk for underactive thyroid [OR 1.13 (95% CI 1.04, 1.22)]. Birthweight was not associated with other thyroid or autoimmune disorders. High birthweight was associated with later-life thyroid and autoimmune conditions while low birthweight was associated with underactive thyroid. Preconception and prenatal interventions aimed at reducing the risk of both high and low birthweights may reduce the burden of later-life thyroid and autoimmune conditions.

Entities:  

Keywords:  Birthweight; autoimmune disease; hyperthyroid; hypothyroid; lupus; postmenopausal women; rheumatoid arthritis; thyroid

Mesh:

Year:  2021        PMID: 34658316      PMCID: PMC9013724          DOI: 10.1017/S204017442100057X

Source DB:  PubMed          Journal:  J Dev Orig Health Dis        ISSN: 2040-1744            Impact factor:   3.034


  64 in total

Review 1.  The developmental origins of adult disease.

Authors:  D J P Barker
Journal:  J Am Coll Nutr       Date:  2004-12       Impact factor: 3.169

Review 2.  Graves' disease, multinodular goiter and subclinical hyperthyroidism.

Authors:  Pierre Bel Lassen; Aglaia Kyrilli; Maria Lytrivi; Bernard Corvilain
Journal:  Ann Endocrinol (Paris)       Date:  2018-09-25       Impact factor: 2.478

Review 3.  Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-analysis.

Authors:  Martin Feller; Marieke Snel; Elisavet Moutzouri; Douglas C Bauer; Maria de Montmollin; Drahomir Aujesky; Ian Ford; Jacobijn Gussekloo; Patricia M Kearney; Simon Mooijaart; Terry Quinn; David Stott; Rudi Westendorp; Nicolas Rodondi; Olaf M Dekkers
Journal:  JAMA       Date:  2018-10-02       Impact factor: 56.272

Review 4.  The role of stress-response systems for the pathogenesis and progression of MS.

Authors:  Stefan M Gold; David C Mohr; Inge Huitinga; Peter Flachenecker; Esther M Sternberg; Christoph Heesen
Journal:  Trends Immunol       Date:  2005-10-07       Impact factor: 16.687

5.  Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus.

Authors:  M A Gutiérrez; M E Garcia; J A Rodriguez; S Rivero; S Jacobelli
Journal:  Lupus       Date:  1998       Impact factor: 2.911

6.  Fetal programming of the hypothalamic-pituitary-adrenal (HPA) axis: low birth weight and central HPA regulation.

Authors:  Alexandra M V Ward; Holly E Syddall; Peter J Wood; George P Chrousos; David I W Phillips
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

Review 7.  Hyperthyroidism.

Authors:  Simone De Leo; Sun Y Lee; Lewis E Braverman
Journal:  Lancet       Date:  2016-03-30       Impact factor: 79.321

8.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Authors:  JoAnn E Manson; Rowan T Chlebowski; Marcia L Stefanick; Aaron K Aragaki; Jacques E Rossouw; Ross L Prentice; Garnet Anderson; Barbara V Howard; Cynthia A Thomson; Andrea Z LaCroix; Jean Wactawski-Wende; Rebecca D Jackson; Marian Limacher; Karen L Margolis; Sylvia Wassertheil-Smoller; Shirley A Beresford; Jane A Cauley; Charles B Eaton; Margery Gass; Judith Hsia; Karen C Johnson; Charles Kooperberg; Lewis H Kuller; Cora E Lewis; Simin Liu; Lisa W Martin; Judith K Ockene; Mary Jo O'Sullivan; Lynda H Powell; Michael S Simon; Linda Van Horn; Mara Z Vitolins; Robert B Wallace
Journal:  JAMA       Date:  2013-10-02       Impact factor: 56.272

Review 9.  Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay.

Authors:  Paola Conigliaro; Arianna D'Antonio; Sara Pinto; Maria Sole Chimenti; Paola Triggianese; Mario Rotondi; Roberto Perricone
Journal:  Autoimmun Rev       Date:  2020-03-29       Impact factor: 9.754

10.  Low Birth Weight and Risk of Later-Life Physical Disability in Women.

Authors:  Cassandra N Spracklen; Kelli K Ryckman; Jennifer G Robinson; Marcia L Stefanick; Gloria E Sarto; Stephen D Anton; Robert B Wallace
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-04-01       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.